Literature DB >> 14715813

Disseminated mucormycosis in a patient with acute myeloblastic leukemia misdiagnosed as infection by Enterococcus faecium.

S Sammassimo1, S Mazzotta, M Tozzi, S Gentili, M Lenoci, R Santopietro, A Bucalossi, M Bocchia, F Lauria.   

Abstract

Mucormycosis is a rare complication in cancer patients. This report presents the case of a acute myeloblastic leukemia patient who developed an ascending paralysis due to disseminated mucormycosis. The presentation was unusual because the early symptoms were fever and pain, and the disease was misdiagnosed because of a concomitant infection by Enterococcus faecium.

Entities:  

Mesh：

Year:  2004        PMID： 14715813      PMCID： PMC321679          DOI： 10.1128/JCM.42.1.487-489.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Mucormycosis in hematologic malignancies: an emerging fungal infection.

Authors:  A Nosari; P Oreste; M Montillo; G Carrafiello; M Draisci; G Muti; A Molteni; E Morra
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

Review 2.  The challenge of invasive fungal infection.

Authors:  B E de Pauw; F Meunier
Journal:  Chemotherapy       Date:  1999-06       Impact factor: 2.544

3.  Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections.

Authors:  V Krcmery; E Kunova; Z Jesenska; J Trupl; S Spanik; J Mardiak; M Studena; E Kukuckova
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

Review 4.  Management of fever in patients with cancer and treatment-induced neutropenia.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

5.  Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis.

Authors:  H F Guiot; W E Fibbe; J W van 't Wout
Journal:  Clin Infect Dis       Date:  1994-04       Impact factor: 9.079

6.  Systemic zygomycosis diagnosed by fine needle aspiration and confirmed with enzyme immunoassay.

Authors:  S A Levy; K W Schmitt; L Kaufman
Journal:  Chest       Date:  1986-07       Impact factor: 9.410

7.  Favorable outcome of invasive aspergillosis in patients with acute leukemia.

Authors:  P A Burch; J E Karp; W G Merz; J E Kuhlman; E K Fishman
Journal:  J Clin Oncol       Date:  1987-12       Impact factor: 44.544

8.  Electrophoretic and immunoblot analyses of Rhizopus arrhizus antigens.

Authors:  D R Wysong; A R Waldorf
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

9.  Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen.

Authors:  E J Bow; R Loewen; M S Cheang; B Schacter
Journal:  Clin Infect Dis       Date:  1995-08       Impact factor: 9.079

10.  Mucormycosis in the BMT population.

Authors:  V A Morrison; P B McGlave
Journal:  Bone Marrow Transplant       Date:  1993-05       Impact factor: 5.483
View more
  2 in total

1.  Successful outcome of mucormycosis in two children on induction therapy for acute lymphoblastic leukemia.

Authors:  Anshul Gupta; Sandeep Jain; Charu Agrawal; Gauri Kapoor
Journal:  Indian J Med Paediatr Oncol       Date:  2013-10

Review 2.  Mucormycosis in a surgical defect masquerading as osteomyelitis: a case report and review of literature.

Authors:  Ashwini Kumar Mengji; Uday Shankar Yaga; Nishanth Gollamudi; Bhanu Prakash; Edunuri Rajashekar
Journal:  Pan Afr Med J       Date:  2016-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.